Randomized placebo-controlled trial of acetyl-L-carnitine (ALC) for the prevention of taxane induced neuropathy phase III

eagle-i ID

Resource Type

Properties

1. ClinicalTrials.gov url

   http://www.clinicaltrials.gov/ct2/show/NCT00775645?term=S0715&rank=1

2. Intervention

   Placebo

3. Intervention

   Acetyl-L-carnitine

4. Additional Topic(s)

   Neuralgia

5. Additional Topic(s)

   Neuropathy

6. Resource Description

   This randomized phase III trial is studying acetyl-L-carnitine to see how well it works compared with a placebo in preventing neuropathy in women with stage I, stage II, or stage III breast cancer undergoing chemotherapy.

7. Contact

   Berenberg, Jeffrey

8. PI

   Berenberg, Jeffrey

9. Topic

   breast cancer

10. Funded by

    SWOG

11. Phase

    Phase 3 clinical trial

12. Performed by

    Clinical Protocol & Data Management Shared Resource